HSP90AA1 and cancer: To the best of our knowledge, this is the first study to assess the expression of HSP90β, TRAP1 and STIP1 in peripheral blood and bone marrow lymphocytes and the role of anti-PD-1 immunotherapy on HSP90 expression in cancer patients.